Goodwill of EAGLE PHARMACEUTICALS, INC. from 31 Dec 2015 to 30 Jun 2023

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
EAGLE PHARMACEUTICALS, INC. quarterly Goodwill in USD history and change rate from 31 Dec 2015 to 30 Jun 2023.
  • EAGLE PHARMACEUTICALS, INC. Goodwill for the quarter ending 30 Jun 2023 was $45,033,000, a 4.6% increase year-over-year.
Source SEC data
View on sec.gov
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Change (%)

EAGLE PHARMACEUTICALS, INC. Quarterly Goodwill (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2023 $45,033,000 +$1,976,000 +4.6% 30 Jun 2023 10-Q/A 09 Aug 2023 2023 Q2
Q1 2023 $45,033,000 +$5,290,000 +13% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $45,033,000 +$5,290,000 +13% 31 Dec 2022 10-Q/A 09 Aug 2023 2023 Q2
Q3 2022 $41,794,000 +$2,051,000 +5.2% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $43,057,000 +$3,314,000 +8.3% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $39,743,000 $0 0% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $39,743,000 $0 0% 31 Dec 2021 10-K 23 Mar 2023 2022 FY
Q3 2021 $39,743,000 $0 0% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $39,743,000 $0 0% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $39,743,000 $0 0% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $39,743,000 $0 0% 31 Dec 2020 10-K 08 Mar 2022 2021 FY
Q3 2020 $39,743,000 $0 0% 30 Sep 2020 10-Q 02 Nov 2020 2020 Q3
Q2 2020 $39,743,000 $0 0% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $39,743,000 $0 0% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 $39,743,000 $0 0% 31 Dec 2019 10-K 05 Mar 2021 2020 FY
Q3 2019 $39,743,000 $0 0% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $39,743,000 $0 0% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 $39,743,000 $0 0% 31 Mar 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 $39,743,000 $0 0% 31 Dec 2018 10-K 02 Mar 2020 2019 FY
Q3 2018 $39,743,000 $0 0% 30 Sep 2018 10-Q 01 Nov 2018 2018 Q3
Q2 2018 $39,743,000 $0 0% 30 Jun 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 $39,743,000 $0 0% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 $39,743,000 $0 0% 31 Dec 2017 10-K 28 Feb 2019 2018 FY
Q3 2017 $39,743,000 30 Sep 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 $39,743,000 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 $39,743,000 31 Mar 2017 10-Q 08 May 2017 2017 Q1
Q4 2016 $39,743,000 +$39,743,000 31 Dec 2016 10-K 26 Feb 2018 2017 FY
Q4 2015 $0 31 Dec 2015 10-K 15 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.